SRx Competitors
| SRXH Stock | 0.14 0.01 6.67% |
SRx Health vs Beyond Air Correlation
Good diversification
The correlation between SRx Health Solutions and XAIR is -0.08 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding SRx Health Solutions and XAIR in the same portfolio, assuming nothing else is changed.
Moving against SRx Stock
| 0.64 | 301293 | Sanbo Hospital Management | PairCorr |
| 0.55 | CHE | Chemed Corp | PairCorr |
| 0.51 | CNC | Centene Corp | PairCorr |
| 0.48 | BKD | Brookdale Senior Living Buyout Trend | PairCorr |
| 0.48 | MOH | Molina Healthcare | PairCorr |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of SRx Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
SRx Health Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between SRx Health and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of SRx and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of SRx Health Solutions does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between SRx Stock performing well and SRx Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze SRx Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| RDGT | 6.00 | 0.86 | 0.11 | 1.47 | 6.72 | 8.84 | 91.56 | |||
| BOLT | 3.20 | 0.28 | 0.06 | 0.64 | 3.84 | 8.22 | 18.19 | |||
| TNON | 2.42 | (0.41) | 0.00 | (0.19) | 0.00 | 5.98 | 16.03 | |||
| TRIB | 4.29 | 0.20 | 0.02 | 1.13 | 5.13 | 12.86 | 64.13 | |||
| CLRB | 4.61 | (0.08) | (0.01) | 0.00 | 6.02 | 7.66 | 30.55 | |||
| SNSE | 5.28 | 0.12 | 0.01 | 4.36 | 5.90 | 17.33 | 36.61 | |||
| AEON | 4.54 | 0.52 | 0.08 | 0.91 | 5.39 | 10.34 | 33.74 | |||
| MRKR | 5.21 | 0.94 | 0.16 | 4.96 | 5.18 | 12.79 | 28.69 | |||
| GELS | 4.63 | (0.11) | 0.01 | 0.03 | 4.82 | 8.33 | 55.89 | |||
| XAIR | 7.25 | 0.56 | 0.04 | (0.09) | 6.29 | 14.46 | 163.02 |
Cross Equities Net Income Analysis
Compare SRx Health Solutions and related stocks such as Ridgetech, Bolt Biotherapeutics, and Tenon Medical Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RDGT | (3.7 K) | 8.1 M | (14.3 M) | (25.4 M) | 856.6 K | 447.2 K | (5.6 M) | (17.1 M) | (926.3 K) | (5.8 M) | (8.1 M) | (3.2 M) | (21.1 M) | (4.2 M) | 10.2 M | 9.2 M | 9.6 M |
| BOLT | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (30.5 M) | (60.7 M) | (98.6 M) | (88.1 M) | (69.2 M) | (63.1 M) | (56.8 M) | (59.6 M) |
| TNON | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (585.2 K) | (7 M) | (18.9 M) | (15.6 M) | (13.7 M) | (12.3 M) | (12.9 M) |
| TRIB | (3.4 M) | 15.6 M | 17.3 M | 10.3 M | 17.2 M | 21.8 M | (100.6 M) | (40.3 M) | 2.4 M | (4.1 M) | (6.4 M) | 875 K | (41 M) | (24 M) | (31.8 M) | (28.6 M) | (27.2 M) |
| CLRB | (815.3 K) | (7.4 M) | (8.8 M) | (10.8 M) | (8.1 M) | (5.5 M) | (6.2 M) | (13.6 M) | (13.2 M) | (14.1 M) | (15.1 M) | (24 M) | (28.6 M) | (42.8 M) | (44.6 M) | (40.1 M) | (38.1 M) |
| SNSE | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (16.7 M) | (20.1 M) | (36.8 M) | (48.8 M) | (34.1 M) | (30.2 M) | (27.1 M) | (28.5 M) |
| AEON | 172.9 M | 172.9 M | 172.9 M | 172.9 M | 172.9 M | 172.9 M | 172.9 M | 172.9 M | 172.9 M | 172.9 M | (32.9 M) | (55.6 M) | (52.6 M) | (384.6 M) | 42 M | 37.8 M | 39.7 M |
| MRKR | (1.1 M) | (2 M) | (5.9 M) | (5.5 M) | (30.9 M) | (34.1 M) | (2.5 M) | (11 M) | (148 M) | (21.4 M) | (28.7 M) | (41.9 M) | (29.9 M) | (8.2 M) | (10.7 M) | (9.7 M) | (10.1 M) |
| GELS | (375.6 K) | (375.6 K) | (375.6 K) | (375.6 K) | (375.6 K) | (375.6 K) | (375.6 K) | (375.6 K) | (375.6 K) | (375.6 K) | (648.9 K) | (3.4 M) | (3.5 M) | (3.5 M) | (6.6 M) | (6 M) | (5.7 M) |
| XAIR | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (4.8 M) | (3.7 M) | (29.7 K) | (18 M) | (6.6 M) | (19.9 M) | (22.9 M) | (43.2 M) | (55.8 M) | (60.2 M) | (46.6 M) | (42 M) | (39.9 M) |
SRx Health Solutions and related stocks such as Ridgetech, Bolt Biotherapeutics, and Tenon Medical Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in SRx Health Solutions financial statement analysis. It represents the amount of money remaining after all of SRx Health Solutions operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.SRx Health Competitive Analysis
The better you understand SRx Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, SRx Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across SRx Health's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
SRx Health Competition Performance Charts
Five steps to successful analysis of SRx Health Competition
SRx Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by SRx Health Solutions in relation to its competition. SRx Health's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of SRx Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact SRx Health's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to SRx Health Solutions, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your SRx Health position
In addition to having SRx Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Toys Thematic Idea Now
Toys
Companies producing and distributing toys and different gaming products for kids. The Toys theme has 31 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Toys Theme or any other thematic opportunities.
| View All Next | Launch |
Check out SRx Health Correlation with its peers. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is there potential for Health Care Providers & Services market expansion? Will SRx introduce new products? Factors like these will boost the valuation of SRx Health. If investors know SRx will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about SRx Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of SRx Health Solutions is measured differently than its book value, which is the value of SRx that is recorded on the company's balance sheet. Investors also form their own opinion of SRx Health's value that differs from its market value or its book value, called intrinsic value, which is SRx Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because SRx Health's market value can be influenced by many factors that don't directly affect SRx Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SRx Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if SRx Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, SRx Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.